Nephros (NEPH) Cash & Equivalents (2010 - 2026)
Nephros' quarterly Cash & Equivalents came in at $4.0 million in Q1 2026, down 1.54% year-on-year from $4.1 million in Q1 2025, and down 25.59% quarter-over-quarter from $5.4 million in Q4 2025.
Nephros has reported Cash & Equivalents for 17 years, with the latest figure at $4.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents fell 1.54% year-over-year to $4.0 million; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (down 1.54% YoY), and the FY2025 full-year result was $5.4 million, up 43.62% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $4.0 million, down from $5.4 million in the prior quarter.
- The five-year high for Cash & Equivalents was $5.4 million in Q1 2022, with the low at $2.5 million in Q3 2024.
- Average Cash & Equivalents over 5 years is $4.2 million, with a median of $4.1 million recorded in 2023.
- Year-over-year, Cash & Equivalents plunged 49.52% in 2022 and surged 110.46% in 2025.
- Tracing NEPH's Cash & Equivalents over 5 years: stood at $3.6 million in 2022, then advanced by 18.52% to $4.3 million in 2023, then declined by 12.7% to $3.8 million in 2024, then jumped by 43.62% to $5.4 million in 2025, then declined by 25.59% to $4.0 million in 2026.
- The last three Cash & Equivalents figures came in at $4.0 million (Q1 2026), $5.4 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 2.01 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 813.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 1.66 Bn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 521.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 561.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 124.90 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 1.06 Bn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.02 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 222.53 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn | 4.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.02 Mn |
| Dec 31, 2025 | 5.40 Mn |
| Sep 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 5.07 Mn |
| Mar 31, 2025 | 4.08 Mn |
| Dec 31, 2024 | 3.76 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 3.63 Mn |
| Dec 31, 2023 | 4.31 Mn |
| Sep 30, 2023 | 4.62 Mn |
| Jun 30, 2023 | 4.06 Mn |
| Mar 31, 2023 | 3.84 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Sep 30, 2022 | 3.94 Mn |
| Jun 30, 2022 | 4.18 Mn |
| Mar 31, 2022 | 5.42 Mn |
| Dec 31, 2021 | 6.97 Mn |
| Sep 30, 2021 | 7.35 Mn |
| Jun 30, 2021 | 8.28 Mn |
| Mar 31, 2021 | 8.16 Mn |
| Dec 31, 2020 | 8.25 Mn |
| Sep 30, 2020 | 5.16 Mn |
| Jun 30, 2020 | 7.05 Mn |
| Mar 31, 2020 | 8.96 Mn |
| Dec 31, 2019 | 4.17 Mn |
| Sep 30, 2019 | 3.86 Mn |
| Jun 30, 2019 | 4.32 Mn |
| Mar 31, 2019 | 3.61 Mn |
| Dec 31, 2018 | 4.58 Mn |
| Sep 30, 2018 | 5.32 Mn |
| Jun 30, 2018 | 3.48 Mn |
| Mar 31, 2018 | 1.82 Mn |
| Dec 31, 2017 | 2.19 Mn |
| Sep 30, 2017 | 150,000.00 |
| Jun 30, 2017 | 301,000.00 |
| Mar 31, 2017 | 803,000.00 |
| Dec 31, 2016 | 275,000.00 |
| Sep 30, 2016 | 807,000.00 |
| Jun 30, 2016 | 1.60 Mn |
| Mar 31, 2016 | 701,000.00 |
| Dec 31, 2015 | 1.25 Mn |
| Sep 30, 2015 | 1.81 Mn |
| Jun 30, 2015 | 1.04 Mn |
| Mar 31, 2015 | 367,000.00 |
| Dec 31, 2014 | 1.28 Mn |
| Dec 31, 2013 | 579,000.00 |
| Mar 31, 2013 | 243,000.00 |
| Dec 31, 2012 | 47,000.00 |
| Sep 30, 2012 | 366,000.00 |
| Jun 30, 2012 | 987,000.00 |
| Mar 31, 2012 | 2.17 Mn |
| Dec 31, 2011 | 1.67 Mn |
| Sep 30, 2011 | 2.12 Mn |
| Jun 30, 2011 | 1.71 Mn |
| Mar 31, 2011 | 2.25 Mn |
| Dec 31, 2010 | 240,000.00 |
| Sep 30, 2010 | 421,000.00 |
| Jun 30, 2010 | 344,000.00 |